Latest Knowledge on the Role of Vitamin D in Hypertension

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Mar 11

PMID 36902110

Authors

Niklas S Jensen

Markus Wehland

Petra M Wise

Daniela Grimm

Affiliations

Soon will be listed here.

Abstract

Hypertension is the third leading cause of the global disease burden, and while populations live longer, adopt more sedentary lifestyles, and become less economically concerned, the prevalence of hypertension is expected to increase. Pathologically elevated blood pressure (BP) is the strongest risk factor for cardiovascular disease (CVD) and related disability, thus making it imperative to treat this disease. Effective standard pharmacological treatments, i.e., diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blocker (ARBs), beta-adrenergic receptor blockers (BARBs), and calcium channel blockers (CCBs), are available. Vitamin D (vitD) is known best for its role in bone and mineral homeostasis. Studies with vitamin D receptor (VDR) knockout mice show an increased renin-angiotensin-aldosterone system (RAAS) activity and increased hypertension, suggesting a key role for vitD as a potential antihypertensive agent. Similar studies in humans displayed ambiguous and mixed results. No direct antihypertensive effect was shown, nor a significant impact on the human RAAS. Interestingly, human studies supplementing vitD with other antihypertensive agents reported more promising results. VitD is considered a safe supplement, proposing its great potential as antihypertensive supplement. The aim of this review is to examine the current knowledge about vitD and its role in the treatment of hypertension.

Citing Articles

Unveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients.

Loh H, Tay S, Koa A, Yong M, Said A, Chai C J Transl Med. 2025; 23(1):296.

PMID: 40055713 PMC: 11889775. DOI: 10.1186/s12967-025-06312-w.

Effects of Vitamin D Supplementation on Blood Pressure in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Clinical Trials.

Ebrahimi R, Masouri M, Salehi Amniyeh Khozani A, Mohammad Soltani S, Nejadghaderi S Health Sci Rep. 2025; 8(3):e70524.

PMID: 40041785 PMC: 11872689. DOI: 10.1002/hsr2.70524.

Correlation of renal biomarkers, electrolyte imbalances and vitamin D levels in hypertensive subjects.

Oluboyo A, Omon E, Oluboyo B, Odewusi O, Edet O Med Int (Lond). 2025; 5(2):20.

PMID: 39990727 PMC: 11843082. DOI: 10.3892/mi.2025.219.

Effect of pre-conception serum vitamin D level on pregnancy outcomes in women undergoing in vitro fertilization with fresh embryo transfer: a retrospective analysis.

Chan A, Ko J, Li R, Chan T, Ng E Reprod Biol Endocrinol. 2025; 23(1):4.

PMID: 39789576 PMC: 11716185. DOI: 10.1186/s12958-025-01343-w.

Sirtuin 1 mediates the pro-survival effects of vitamin D in angiotensin II-induced hypertrophy of H9c2 cardiomyoblasts.

Astani A, Maroofi A, Hekmatimoghaddam S, Sarebanhassanabadi M, Safari F Mol Biol Rep. 2024; 52(1):96.

PMID: 39738677 DOI: 10.1007/s11033-024-10168-6.

References

Meyer M, Watanuki M, Kim S, Shevde N, Pike J . The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol Endocrinol. 2006; 20(6):1447-61. DOI: 10.1210/me.2006-0031. View

Bouillon R . Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol. 2017; 13(8):466-479. DOI: 10.1038/nrendo.2017.31. View

Sacks F, Svetkey L, Vollmer W, Appel L, Bray G, Harsha D . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1):3-10. DOI: 10.1056/NEJM200101043440101. View

Zehnder D, Bland R, Chana R, Wheeler D, Howie A, Williams M . Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002; 13(3):621-629. DOI: 10.1681/ASN.V133621. View

Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm B . Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010; 411(17-18):1354-60. DOI: 10.1016/j.cca.2010.05.037. View

Vaidya A, Sun B, Larson C, Forman J, Williams J . Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab. 2012; 97(7):2456-65. PMC: 3387405. DOI: 10.1210/jc.2012-1156. View

Morfis L, Smerdely P, Howes L . Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J Hypertens. 1997; 15(11):1271-6. DOI: 10.1097/00004872-199715110-00011. View

Bernini G, Carrara D, Bacca A, Carli V, Virdis A, Rugani I . Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls. J Endocrinol Invest. 2013; 36(4):216-20. DOI: 10.1007/BF03347275. View

Kolek O, Hines E, Jones M, LeSueur L, Lipko M, Kiela P . 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005; 289(6):G1036-42. DOI: 10.1152/ajpgi.00243.2005. View

10.

Dao H, Essalihi R, Bouvet C, Moreau P . Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res. 2005; 66(2):307-17. DOI: 10.1016/j.cardiores.2005.01.012. View

11.

OShea P, Griffin T, Fitzgibbon M . Hypertension: The role of biochemistry in the diagnosis and management. Clin Chim Acta. 2016; 465:131-143. DOI: 10.1016/j.cca.2016.12.014. View

12.

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

13.

Haussler M, Jurutka P, Mizwicki M, Norman A . Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011; 25(4):543-59. DOI: 10.1016/j.beem.2011.05.010. View

14.

Peterlik M, Cross H . Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005; 35(5):290-304. DOI: 10.1111/j.1365-2362.2005.01487.x. View

15.

Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D . Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008; 74(2):170-9. DOI: 10.1038/ki.2008.101. View

16.

Nemere I, Safford S, Rohe B, DeSouza M, Farach-Carson M . Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):281-5. DOI: 10.1016/j.jsbmb.2004.03.031. View

17.

Brumbaugh P, Haussler M . 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. I. Association of 1 alpha,25-dihydroxycholecalciferol with intestinal mucosa chromatin. J Biol Chem. 1974; 249(4):1251-7. View

18.

Si S, Mo M, Cheng H, Peng Z, Alifu X, Zhou H . The Association of Vitamin D and Its Pathway Genes' Polymorphisms with Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. Nutrients. 2022; 14(11). PMC: 9183033. DOI: 10.3390/nu14112355. View

19.

Olsen M, Angell S, Asma S, Boutouyrie P, Burger D, Chirinos J . A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016; 388(10060):2665-2712. DOI: 10.1016/S0140-6736(16)31134-5. View

20.

Resnick L, Muller F, LARAGH J . Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986; 105(5):649-54. DOI: 10.7326/0003-4819-105-5-649. View